New MS Drug Approved By FDA Despite Teva's Opposition
Biogen Idec Inc. won U.S. Food and Drug Administration approval Wednesday for multiple sclerosis treatment Tecfidera, thwarting Teva Pharmaceutical Industries Ltd.'s attempt to delay the product by raising safety concerns and...To view the full article, register now.
Already a subscriber? Click here to view full article